Multi-resistant pathogens become dangerous when they enter the body through wounds and cause infections. Researchers from the Gießen University want to get better insights in the core of these pathogens to hinder their spreading.Artikel lesen
Prof. Dr. Joybrato Mukherjee, the President of the Justus Liebig University Giessen, speaks about top-level research and scientific excellence in science as well as current challenges in medicine.Artikel lesen
Prof. Dr. Harald Renz is medical director of the University Hospital Marburg. As a laboratory physician, he knows exactly how important individualized clinical diagnostics are.Artikel lesen
Prof. Dr. Ralph Schermuly is an expert in the field of experimental pathophysiology and pulmonary hypertension. Since 2011 he and his team have been conducting research on causes and disease mechanisms to better understand pulmonary hypertension.Artikel lesen
At the Center for Unknown and Rare Diseases (ZusE) at Marburg University Hospital, patients find help from Prof. Juergen Schaefer.Artikel lesen
DFG President Prof. Dr. Katja Becker has dedicated her life as a researcher to one goal in particular: to develop new drugs and diagnostics against poverty-associated and neglected infectious diseases.Artikel lesen
We are Healthcare Mittelhessen
Education, research, economy: The intensive networking in the health sector and medicine makes the location of Central Hesse special throughout Germany.
Trend report: Focus on cardiovascular research
Scientists around the globe are currently conducting research on cardiac insufficiency, infarcts, pulmonary hypertension or atherosclerosis. Their goal is to gain a better understanding of the development of cardiovascular diseases at the molecular level.
Trend report telemedicine: video chat with the doctor
The spread of the corona crisis is driving the use of telemedicine via video chats. Patients thereby avoid the risk of infection in the waiting room.
How Big Data accelerates drug development
The contract research organization Alcedis, founded in Giessen, knows how to accelerate the drug development process with the help of innovative software systems - for the benefit of medicine and patients.
Dr. David Eckensberger is Head of International Affairs at Hessen Trade & Invest. In this interview, he tells us why Central Hessen is a strong location for companies and how businesses are managing the Corona pandemic.Artikel lesen
Scientists are racing to get the Corona pandemic under control. Research institutes and companies from Central Hessen are making major contributions and developing new long-term research strategies.Artikel lesen